chronic myelomonocytic leukemia
Showing NaN - NaN of 18
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
-
Tampa, Florida
- +4 more
Nov 11, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)
Active, not recruiting
- Acute Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
-
Baltimore, Maryland
- +3 more
Aug 8, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)
Terminated
- Myelodysplastic Syndrome
- +2 more
- GVAX
- +6 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)
Completed
- Myelodysplastic Syndrome
- +3 more
-
Tampa, Florida
- +5 more
Jan 14, 2022
MDS, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia Trial in Boston (Inqovi)
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 29, 2021
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts Trial in
Completed
- Acute Myeloid Leukemia
- +2 more
- GM-K562/leukemia cell vaccine
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 15, 2020
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)
Completed
- Myelodysplastic Syndromes
- +2 more
- Panobinostat (LBH589)
- 5-Azacytidine
-
Augusta, Georgia
- +37 more
Jul 20, 2020
MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)
Completed
- Myelodysplastic Syndromes
- +3 more
- rigosertib sodium
-
Stanford, California
- +34 more
Jun 29, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +14 more
- Azacitidine
- +2 more
-
Scottsdale, Arizona
- +233 more
Dec 8, 2016
Myelofibrosis, Myeloid Metaplasia, Agnogenic Myeloid Metaplasia Trial in Boston (Imatinib mesylate)
Completed
- Myelofibrosis
- +3 more
- Imatinib mesylate
-
Boston, Massachusetts
- +1 more
Dec 22, 2016
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +50 more
- Akt inhibitor MK2206
- +2 more
-
Birmingham, Alabama
- +24 more
Apr 28, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014